Genotyping of Marcoux et al.’s cohort showed also significant incidence of TP53- and RB1-mutations in the LACs before undergoing SCLC-transformation and after having transformed as well as in the de novo EGFRM+ SCLC specimens [195]. The gene discussed is RB1; the disease is small cell lung carcinoma.